Parenteral Nutrition Fundamentals: Indications, Macronutrient Compounding, Electrolytes, and Refeeding Risk

Clinical Nutrition · Inpatient Care

Parenteral Nutrition Fundamentals: Indications, Macronutrient Compounding, Electrolytes, and Refeeding Risk

By gomdori, MD15 min readInpatient · ICU

Executive Summary

Parenteral nutrition (PN) is indicated when the gut cannot meet caloric needs for ≥7 days. Targets are typically 25-30 kcal/kg/day and 1.2-2.0 g protein/kg/day, balanced as 50-60% dextrose, 20-30% lipid, and 15-20% amino acids. The most preventable disaster is refeeding syndrome — give thiamine 200-300 mg IV first, start at 5-10 kcal/kg/day in high-risk patients, and replete phosphate/potassium/magnesium daily. Long-term PN demands central venous access (PICC, tunneled, port), strict aseptic technique, lipid rotation to prevent IFALD, and cycling to limit hepatic steatosis.

25-30kcal/kg/day target
1.2-2.0g protein/kg/day
7 dEN trial before PN
2.5g/kg/day max lipid

S1. Indications and Risk Stratification

Parenteral nutrition delivers macro- and micronutrients directly into the systemic circulation, bypassing the GI tract. It is reserved for patients who cannot meet at least 60% of caloric needs by enteral or oral routes for an anticipated duration of 7 or more days. The decision is never trivial: PN doubles infectious complications and adds metabolic risk compared with enteral nutrition, so the gut should always be used when at all possible — even small trickle feeds preserve gut barrier integrity, IgA secretion, and bile acid recirculation.

EN-vs-PN decision framework

Absolute indications for PN include short bowel syndrome (residual jejunum <100 cm without colon, <60 cm with colon), high-output enterocutaneous fistula (>500 mL/day) where downstream feeding is impossible, severe intestinal pseudo-obstruction (CIPO), mesenteric ischemia awaiting revascularization, and chemotherapy-induced mucositis with grade 3-4 oral intake failure. Relative indications include severe acute pancreatitis intolerant of jejunal feeds (a small minority), prolonged ileus >7 days, and high-risk perioperative malnutrition before major GI/oncologic surgery (start PN 7-10 days preoperatively if NRS-2002 ≥5).

ScenarioRecommendationNotes
Functional gut, oral intake <60% × 5-7 dOral supplements, then ENPN not indicated
NPO <7 d, well-nourishedIV maintenance fluidsBrief starvation tolerated
Anticipated NPO ≥7 d, well-nourishedPN day 7 if EN still impossibleEPaNIC supports late initiation
NRS-2002 ≥5 or NUTRIC ≥5, NPOPN within 3-5 daysHigh nutritional risk
Short bowel, high fistula, CIPOPN immediatelyOften long-term/home PN
Severe pancreatitis intolerant of jejunal feedsPN after 5-7 d EN failureMost tolerate jejunal EN

Timing in critically ill patients

The landmark EPaNIC trial (NEJM 2011) randomized 4640 ICU patients to early supplemental PN within 48 hours versus delayed PN starting on day 8 if EN remained inadequate. Late initiation reduced ICU stay by 1 day, decreased new infections (22.8% vs 26.2%), shortened ventilator time, and accelerated organ failure recovery A. The takeaway: in well-nourished ICU patients, do not rush PN — give EN every chance to work, accept hypocaloric feeding for the first week, and start PN on day 7-8 only if needed.

For high-risk malnourished patients (BMI <18.5, >10% weight loss, NRS-2002 ≥5), the calculus changes. ASPEN/SCCM guidelines recommend initiating PN as soon as feasible (within 3-5 days) when EN is contraindicated. The risk of further nutritional deterioration outweighs PN's complication burden in this group.

ℹ
Trickle feeding philosophyEven when full EN is impossible, "trophic" feeds at 10-20 mL/hr through an NG or NJ tube preserve gut barrier function. Combine with PN for nutrients — never skip the gut entirely if access exists.

S2. Macronutrient Targets

PN macronutrient prescription begins with total energy and protein targets, then divides remaining calories between dextrose and lipid in a 60:40 to 70:30 ratio (non-protein calories). Indirect calorimetry is the gold standard but rarely available — most institutions use weight-based predictive equations.

PN macronutrient distributionPie-style breakdown of PN energy from dextrose, lipid, and amino acids with calorie densities annotated.PN Macronutrient Distribution (Typical Adult ICU)Dextrose50-55%Lipid25-30%AA15-20%Caloric densitiesDextrose3.4 kcal/gLipid 20%2.0 kcal/mLAA (protein)4.0 kcal/gEnergy target25-30 kcal/kg/dProtein target1.2-2.0 g/kg/dGlucose max5 mg/kg/minLipid max2.5 g/kg/d
Energy distribution in standard adult PN; protein calories are conventionally counted but excluded from "non-protein calorie" calculations.

Protein (amino acids)

Protein needs are dictated by metabolic stress and renal function. Healthy maintenance is 0.8 g/kg/day; mild illness 1.0-1.2 g/kg/day; ICU patients 1.2-2.0 g/kg/day; burn patients and CRRT recipients 2.0-2.5 g/kg/day. Use ideal body weight in obesity (BMI >30) targeting 2.0-2.5 g/kg ideal weight. Standard adult amino acid solutions are 8.5-15% (e.g., Aminosyn 10%, Travasol 10%, Clinisol 15%); branched-chain enriched (HepatAmine, Aminosyn-HBC) is reserved for refractory hepatic encephalopathy and offers no survival benefit in routine cirrhosis.

Protein delivery is independent of total calories — when calories are restricted (e.g., obese ICU patient on hypocaloric feeding), protein is preserved at ≥2.0 g/kg ideal weight. This "permissive underfeeding" preserves lean mass without overfeeding.

Carbohydrate and lipid

Dextrose monohydrate provides 3.4 kcal/g (not 4.0 — the monohydrate water adds mass without calories). Concentrations range from 5% to 70%; central-line PN typically uses 40-70% stock. Maximum infusion rate is 5 mg/kg/min in stable adults, but stress hyperglycemia often forces lower rates (3-4 mg/kg/min). Exceeding the maximum drives hepatic steatosis, hyperglycemia, hypercapnia (excess CO₂ from glycolysis), and infection risk.

Lipid emulsions provide essential fatty acids (linoleic, alpha-linolenic) and dense calories (9 kcal/g triglyceride; 1.1 kcal/mL of 10%, 2.0 kcal/mL of 20%, 3.0 kcal/mL of 30%). Five formulations exist: Intralipid (100% soybean, omega-6 heavy, pro-inflammatory), ClinOleic (80% olive/20% soybean, lower omega-6), Lipoplus (50% MCT/50% soybean, faster clearance), SMOFlipid (30% soybean/30% MCT/25% olive/15% fish, balanced), and Omegaven (100% fish oil, salvage for IFALD). For long-term PN, SMOFlipid is preferred because it lowers ALT/bilirubin and reduces IFALD progression versus pure soybean B.

Lipid emulsionCompositionBest useCaveats
Intralipid 20%100% soybean (60% LA, 8% ALA)Short-term PN, EFA repletionPro-inflammatory; IFALD risk long-term
ClinOleic 20%80% olive / 20% soybeanLong-term, lower omega-6Limited US availability
Lipoplus 20%50% MCT / 50% LCT soybeanHypertriglyceridemia, faster clearanceLess EFA per gram
SMOFlipid 20%30% soybean/30% MCT/25% olive/15% fishLong-term PN, IFALD preventionHigher cost; FDA-approved adults & peds
Omegaven 10%100% fish oil (EPA, DHA)Salvage for established IFALDInsufficient EFA alone; combine if long term
Parenteral Nutrition Fundamentals — Comparison Comparison table: Parenteral Nutrition Fundamentals — Comparison Central (TPN) PPN Short-term (<2 wk) Long-term (>4 wk) Home PN Description PICC, port, central; concentrated formulations; prolonged use Peripheral; lower osmolarity (<900 mOsm/L); short-term (<2 wk) Acute illness, postop ileus Short bowel, chronic intestinal failure Coordinated multidisciplinary care; significant burden + cost
Parenteral Nutrition Fundamentals — Comparison

S3. Electrolytes, Vitamins, Trace Elements

Electrolyte requirements are highly individual and reflect baseline labs, renal function, GI losses, and refeeding risk. Standard adult daily provisions in PN are sodium 60-150 mEq, potassium 60-100 mEq, calcium 5-15 mEq, magnesium 8-20 mEq, and phosphate 20-40 mmol. Bicarbonate is not added directly — acetate is the buffer (1 mEq acetate yields 1 mEq HCO₃⁻ when metabolized).

ElectrolyteStandard daily PN doseRefeeding/depleted patientCommon limit
Sodium60-150 mEqPer fluid statusRestrict in HF/cirrhosis
Potassium60-100 mEq+20-40 mEq/day≤10 mEq/L peripheral; central up to 80 mEq/L
Calcium5-15 mEq (gluconate)Per ionized CaCa×Phos product <72 to avoid precipitation
Magnesium8-20 mEq (sulfate)16-32 mEqReduce in renal failure
Phosphate20-40 mmol40-60 mmolUse Na or K phosphate per K balance
Acetate50-150 mEqPer acid-baseAdjust Cl:acetate ratio
ChlorideBalance to charge—Avoid excess in hyperchloremic acidosis

Multivitamins and trace elements

A single dose of adult multivitamin (MVI-12 or MVI Adult) added daily provides A, D, E, K (200 mcg in newer formulations), B-complex, folate, biotin, and ascorbate. Thiamine 200-300 mg IV is given separately before initiating PN in any high-risk refeeding patient — multivitamin provides only 6 mg, insufficient to prevent Wernicke-Korsakoff if reserves are depleted. Trace element solutions provide zinc 3-5 mg, copper 0.5-1.5 mg, manganese 60-100 mcg, chromium 10-15 mcg, and selenium 60-100 mcg. Iron is NOT in standard PN trace elements (incompatible with lipid; give as iron sucrose or ferric gluconate separately).

⚠
Manganese accumulation in long-term PNCumulative manganese deposition causes basal ganglia toxicity (parkinsonian features, MRI T1 hyperintensity in globus pallidus). For PN >30 days, omit manganese from trace element solution and check whole-blood Mn quarterly.
Parenteral Nutrition Fundamentals — Procedure Steps Surgical stepper: Parenteral Nutrition Fundamentals — Procedure Steps Parenteral Nutrition Fundamentals — Procedure Steps 1 Indication assessment GI tract non-functional or use contraindicated for ≥7 days; calculate energy needs (25-30 kcal/kg); 2 Access Central catheter (subclavian, IJ) for TPN; PICC for medium-term; PPN via peripheral if short-term 3 Macronutrients Dextrose 50-70% energy; amino acids 1-2 g/kg; lipid 1-1.5 g/kg/day (omega-3 enriched preferred); 24h 4 Refeeding prevention Start at 50% goal × 24h; monitor + replete K+, Mg, phos × 3 days; thiamine 100mg/day; advance gradua 5 Monitoring Daily BMP × 5 days then weekly; LFTs weekly; triglycerides at start; blood cultures if fever; 6 Complications CRBSI: remove line if persistent; PN cholestasis: minimize lipid, cyclic PN, fish oil; hyperglycemia
Parenteral Nutrition Fundamentals — Procedure Steps

S4. Compounding Worked Example

A 70 kg ICU patient with anticipated NPO >7 days, no organ failure, BMI 24, NRS-2002 = 5. Total energy target 25 kcal/kg = 1750 kcal/day. Protein target 1.5 g/kg = 105 g/day = 420 protein calories.

Non-protein calories = 1750 − 420 = 1330 kcal. Distribute 60% as dextrose (798 kcal) and 40% as lipid (532 kcal):

  • Dextrose: 798 ÷ 3.4 kcal/g = 235 g. Use 70% dextrose stock = 235 ÷ 0.7 = 336 mL of D70%. Glucose infusion rate = 235 g ÷ 70 kg ÷ 1440 min × 1000 = 2.3 mg/kg/min ✓ (well below 5 mg/kg/min ceiling).
  • Lipid: 532 ÷ 2.0 kcal/mL = 266 mL of 20% SMOFlipid (provides 53 g lipid = 0.76 g/kg). Below 2.5 g/kg/day max ✓.
  • Amino acids: 105 g protein. Use 15% Clinisol = 105 ÷ 0.15 = 700 mL.

Total volume = 336 (dextrose) + 266 (lipid) + 700 (AA) + ~200 mL electrolytes/additives = ~1500 mL. If patient needs additional fluid, supplement with maintenance crystalloid through a separate lumen.

Daily additives: NaCl 80 mEq + Na acetate 40 mEq, KCl 60 mEq + K phosphate 20 mmol (= 30 mEq K), Ca gluconate 10 mEq, MgSO₄ 12 mEq, MVI 1 vial, trace elements 1 vial. Insulin 0.05-0.1 unit per gram dextrose (start 0.05) added to bag if BG >180 mg/dL.

ComponentAmountCaloriesProvides
D70% dextrose336 mL798 kcal235 g carbohydrate
SMOFlipid 20%266 mL532 kcal53 g lipid + EFAs
Clinisol 15% AA700 mL420 kcal105 g protein
Total non-additive volume1302 mL1750 kcal25 kcal/kg, 1.5 g protein/kg

Adjustments for renal failure (CRRT)

CRRT removes 6-15 g amino acids/day and water-soluble vitamins. Protein target rises to 2.0-2.5 g/kg/day. Phosphate replacement is critical — CRRT extracts ~7 mmol/L of phosphate, leading to hypophosphatemia within 48 hours. Add 30-50 mmol phosphate per day to the bag, or use phosphate-containing replacement fluid (e.g., Phoxilium).

S5. Monitoring and Refeeding Prevention

Refeeding syndrome

Refeeding syndrome is the single most preventable cause of PN-related death. After prolonged starvation, intracellular cations (phosphate, potassium, magnesium) are depleted; carbohydrate refeeding spikes insulin, driving these cations into cells, while thiamine reserves rapidly exhaust as glucose enters glycolysis. Severe hypophosphatemia (<1.0 mg/dL) precipitates respiratory muscle failure, cardiac dysfunction, hemolysis, and rhabdomyolysis. Wernicke encephalopathy from acute thiamine deficiency adds confusion, ataxia, and ophthalmoplegia.

NICE 2006 high-risk criteria (any one of the following): BMI <16, weight loss >15% in 3-6 months, no nutrition for >10 days, low pre-feed K/Mg/PO₄. Or two of: BMI <18.5, weight loss >10%, no nutrition >5 days, history of alcohol abuse / chemo / antacids / diuretics.

DayEnergy targetAction
Pre-feeding—Thiamine , replete K/Mg/PO₄ to normal range, MVI 1 vial IV
Day 1-35-10 kcal/kg/dayContinue daily K/Mg/PO₄ checks; replete aggressively
Day 4-515 kcal/kg/dayLab checks BID if electrolytes shifting
Day 6-720 kcal/kg/dayDaily labs
Day 8+25-30 kcal/kg/dayReach goal; transition labs to twice weekly

Hyperglycemia management

Target blood glucose 140-180 mg/dL on PN (ICU and ward both). Add insulin to the PN bag at 0.05-0.1 unit per gram dextrose (start 0.05) if BG >180. Persistent hyperglycemia despite 0.2 unit/g warrants separate insulin drip with hourly checks. Sudden cessation of PN risks hypoglycemia from circulating insulin — taper over 1-2 hours by halving the infusion rate, or hang D10W at the prior PN rate for 1 hour.

📋
Standard PN monitoring scheduleDaily for first week: BMP, magnesium, phosphate, glucose q6h, fluid balance, weight. Twice weekly thereafter: CBC, LFTs, prealbumin, triglycerides. Weekly: CRP, transferrin. Monthly: zinc, copper, selenium, manganese (if >30 days PN), 25-OH vitamin D.

Practice Insights: Refeeding Is the Biggest Mortal Risk, Not the PN Formula Itself

(The content below synthesizes published clinical patterns and expert consensus rather than first-person case reports.)After managing parenteral nutrition across hospital nutrition support service, ICU, and an intestinal failure clinic over many years and roughly several hundred PN initiations, the central conviction is that in experienced hands the morbidity attributable to PN itself is far less than the morbidity attributable to refeeding syndrome and to CRBSI — both preventable with the disciplined protocols experienced practice now build into every PN order. In experienced practice, the patients who do worst on PN are not the ones with calculation errors in the macronutrient formula; in practice they are the high-risk-for-refeeding patients who got 100% calorie goal from day 1 without electrolyte prerepletion, and the patients whose central line was used for blood draws (the single highest CRBSI risk practice). PN itself is forgiving when the underlying nutritional physiology is respected. Experienced practice would rather under-feed a malnourished patient for 5 days than precipitate Wernicke or fatal refeeding hypophosphatemia by rushing.

NICE Refeeding Risk Criteria Anchor the Start

in experienced hands, the most consequential first decision is identifying refeeding risk before starting PN. NICE criteria: high risk if any one of (1) BMI <16; (2) unintentional weight loss >15% in 3-6 months; (3) little or no nutritional intake for >10 days; (4) low pre-feeding K+, Mg++, PO4. Moderate risk if any two of (1) BMI 16-18.5; (2) weight loss 10-15%; (3) little intake >5 days; (4) alcohol use, chemotherapy, insulin/diuretic use. For any moderate or high risk patient, start PN at 50% of goal calories on day 1, advance over 5-7 days, give thiamine 200-300 mg IV before/with first dose, replace K+/Mg++/PO4 to high-normal range before starting calories, and monitor electrolytes 1-2x daily through first week.

Thiamine Before Glucose — Always

The single most underappreciated prerefeed step is thiamine repletion. Glucose-driven entry into the cell increases thiamine demand sharply; refeeding glucose into a thiamine-deficient malnourished patient precipitates Wernicke encephalopathy (confusion, ataxia, ophthalmoplegia) and lactic acidosis from blocked pyruvate dehydrogenase. The standard: thiamine 200-300 mg IV given at least 30 minutes before the first PN dose, continued daily for 5-7 days, then daily oral or IV supplementation. The dose is higher than the "100 mg" recommendation from decades past — the modern teaching is to push thiamine generously in any patient at refeeding risk because the downside of excess is negligible and the downside of insufficient is catastrophic.

SMOF Lipid Over Pure Soybean

For lipid emulsion choice, the established preference has shifted to SMOF (soybean + MCT + olive + fish oil mixture) over pure soybean (Intralipid) emulsions. SMOF has lower omega-6:omega-3 ratio, less inflammatory profile, better liver outcomes (lower incidence of PN-associated cholestasis especially in long-term users and infants), and clearer evidence in randomized trials over the past 5-10 years. Pure soybean remains acceptable for short-term use and is still available; for any patient expected to be on PN beyond 2 weeks, SMOF is the default. Lipid dose 1.0-1.5 g/kg/day for stable patients, lower (0.5-1.0 g/kg/day) for hypertriglyceridemia, omit entirely in egg/soy/peanut allergy.

The PN Line Is Sterile Territory

CRBSI prevention is the single biggest infectious morbidity reduction experienced clinicians can build into the workflow, and it rests on three rules: (1) dedicated PN lumen only — the PN port is not used for blood draws, antibiotic administration, or any non-PN purpose; this single rule reduces CRBSI by 40-60%; (2) maximum barrier precautions at insertion + CHG dressing; (3) aseptic hub disinfection 15 seconds with CHG/alcohol scrub before every access. PN through a peripheral line is limited to short-term (under 7-10 days) and lower osmolarity formulas (under 900 mOsm/L); central access is required for prolonged or higher-concentration PN. Tunneled catheters or PICCs for outpatient PN; ports for the most stable long-term home patients.

Illustrative Scenario

A patient in their forties with severe alcohol use disorder and 22 kg weight loss over 4 months was admitted with pancreatitis, BMI 16.2, K+ 3.0, Mg 1.4, PO4 1.8, baseline lactate 1.2. The admitting team initiated PN at full calorie goal (25 kcal/kg) on hospital day 2 without electrolyte prerepletion. On day 3 the patient developed worsening confusion, hyperventilation, hypophosphatemia (PO4 0.9), hypokalemia (K+ 2.4), and lactic acidosis (lactate 5.8) — refeeding syndrome was recognized. PN was held, thiamine 500 mg IV was given, aggressive electrolyte repletion (KCl, MgSO4, sodium and potassium phosphate replacement IV), and PN was restarted at 25% calorie goal with thiamine cover and twice-daily electrolyte monitoring. Patient recovered over 5 days with PN advancement to full goal over 10 days, and was transitioned to enteral feeds and discharged at hospital day 21.

Takeaway: Severe alcohol use + 22 kg weight loss + BMI 16 + low baseline electrolytes is textbook high refeeding risk. Starting PN at full calorie goal without prerepletion and thiamine produced near-fatal refeeding syndrome with Wernicke risk. The cardinal rule is electrolytes to high-normal + thiamine 200-300 mg IV + start at 25-50% calorie goal in high-risk patients.

Practice Pattern Refinements vs Standard Algorithm

  1. NICE refeeding risk screening before initiating PN. BMI, weight loss %, days of intake, baseline electrolytes. High-risk patients start at 25-50% calorie goal with thiamine pre-treatment and electrolytes prerepleted to high-normal range.
  2. Thiamine 200-300 mg IV before first PN dose, continued daily 5-7 days. The "100 mg" recommendation is outdated. Higher doses are safer and prevent Wernicke encephalopathy and lactic acidosis in glucose-stressed thiamine-deficient patients.
  3. SMOF lipid emulsion preferred for PN beyond 2 weeks. Lower omega-6:omega-3 ratio, less inflammatory, better liver outcomes than pure soybean for prolonged use. Pure soybean acceptable for short-term only.
  4. Dedicated PN lumen — no blood draws, no other access. Single highest-impact CRBSI prevention. Combined with maximum barriers, CHG dressing, and 15-second hub scrub before every access, reduces CRBSI by 40-60%.
Parenteral Nutrition — Refeeding-Risk-Stratified Initiation Three-tier refeeding risk stratification with calorie advancement schedule and required prerefeed measures. PN Initiation — Refeeding Risk Drives the Advancement Thiamine first, electrolytes to high-normal, then advance calories Low refeeding risk BMI ≥18.5 ▸ Weight loss <10% 3-6 mo ▸ Intake adequate <5 days ▸ Normal baseline electrolytes Start full calorie goal 25-30 kcal/kg/day 1.2-1.5 g/kg/d protein 1.0-1.5 g/kg/d lipid Thiamine 100 mg × 3 d Moderate refeeding risk 2 of: ▸ BMI 16-18.5 ▸ Weight loss 10-15% ▸ Intake limited >5 days ▸ ETOH / chemo / insulin / diuretic Start at 50% calorie goal Advance over 3-5 days K+/Mg++/PO4 daily × 5d Replete electrolytes pre-feed Thiamine 200 mg × 5-7 d High refeeding risk Any one of: ▸ BMI <16 ▸ Weight loss >15% ▸ Minimal intake >10 days ▸ Low pre-feed K+/Mg++/PO4 Start at 25-50% goal Advance over 5-7 days K+/Mg++/PO4 BID × first week Replete to HIGH-normal Thiamine 300 mg × 5-7 d Daily monitoring (first week) ▸ K+, Mg++, PO4 (most at-risk electrolytes) ▸ Glucose (insulin in PN bag if >180) ▸ Triglycerides on day 2-3 (hold lipid if >400 mg/dL) CRBSI prevention rules ▸ Dedicated PN lumen ONLY — no other access ▸ Maximum barrier insertion + CHG dressing ▸ 15-sec CHG/alcohol hub scrub before every access Lipid emulsion choice ▸ SMOF (soybean + MCT + olive + fish oil) preferred for PN >2 weeks ▸ Lower omega-6:omega-3, less inflammatory, lower PN-associated cholestasis vs pure soybean
RELATED TOOL
Refeeding Syndrome Risk & Feeding Rate — applies the NICE criteria, then shows the starting kcal/kg/day, the electrolyte and thiamine requirements and the monitoring frequency.

S6. Complications, Pearls, and FAQs

ComplicationIncidencePrevention/Management
CLABSI0.5-2 per 1000 catheter-daysAseptic insertion bundle, chlorhexidine dressings, dedicated PN lumen, ethanol locks for home PN
Catheter occlusion10-30% long-termSaline flushes; alteplase 2 mg dwell × 30-120 min for fibrin sheaths
Catheter thrombosis5-20% upper extremityTip placement at SVC-RA junction; DOAC or LMWH if recurrent
IFALD40-60% long-term soybeanSMOFlipid, cycle PN 12-16h, oral/EN as soon as possible, ursodiol 10-15 mg/kg/day
Hyperglycemia30-50%Insulin in bag, target 140-180 mg/dL
Hypertriglyceridemia (>400)10-25%Hold lipid until <400; switch to MCT-containing or fish-oil emulsion
Refeeding syndromeUp to 48% high-riskSlow start, thiamine, daily electrolyte repletion
Metabolic bone disease40-70% long-term PNDEXA annually, calcium/vit D, bisphosphonates if osteoporosis
Aluminum toxicityRare; pediatric/renalFDA limit 5 mcg/kg/day; check Al levels in long-term renal failure
🚑
When to refer to a nutrition support teamAnticipated PN >14 days, pediatric PN, home PN candidate, refeeding syndrome history, hepatic dysfunction on PN, recurrent CLABSI, complex fluid/electrolyte management, transition planning to enteral or oral feeds.

Clinical Pearl

Always give thiamine 200-300 mg IV before the first PN bag in any patient who has had inadequate intake for ≥5 days, has alcohol use disorder, or is on chronic diuretics. Multivitamin alone is insufficient. The cost is trivial; the protection against fatal Wernicke encephalopathy is enormous. Document this in your initial PN order set as a hard stop.

Common Pitfall

Stopping PN abruptly in a patient on insulin causes profound hypoglycemia within 30 minutes — circulating insulin keeps acting after the dextrose source vanishes. Always either taper PN over 1-2 hours by halving the rate, or hang D10W at the same volume rate for 1 hour after PN ends. This is a frequent cause of hypoglycemia codes on the surgical wards.

Clinical Pearl

For patients on PN >7 days, switch from continuous to cyclic infusion (12-16 hours overnight, off during the day). This mimics physiologic feeding patterns, allows daytime mobility, reduces hepatic steatosis, and improves quality of life. Begin by compressing infusion to 20 hours, then 16, then 12 — monitoring glucose tolerance at each step.

Common Pitfall

Underestimating protein needs in obesity and CRRT. A 120 kg patient with BMI 38 on CRRT needs ~150 g protein/day (2.0-2.5 g/kg ideal weight) — not 96 g (0.8 g/kg actual weight). Underdosing accelerates lean mass loss and impairs wound healing. Use ideal body weight or adjusted body weight for protein calculations in obesity, never actual.

Frequently Asked Questions

When should parenteral nutrition be initiated in critically ill adults?

For previously well-nourished ICU patients, initiate PN after 7 days if enteral nutrition is not feasible or tolerated. For high-risk malnourished patients (NRS-2002 ≥5 or NUTRIC ≥5), initiate PN within 3-5 days when EN is contraindicated. Avoid early supplemental PN within the first week as the EPaNIC trial showed harm.

What is refeeding syndrome and how is it prevented?

Refeeding syndrome is intracellular electrolyte shifts (phosphate, potassium, magnesium) and thiamine depletion when nutrition is reintroduced after starvation. Prevention: identify high-risk patients (BMI <16, weight loss >15%, intake <10 days), give thiamine 200-300 mg IV before feeding, start at 5-10 kcal/kg/day, advance over 5-7 days, replete phosphate/potassium/magnesium aggressively, and monitor electrolytes daily for the first week.

Can lipid emulsions be given to patients with hypertriglyceridemia?

Hold or reduce lipids if triglycerides exceed 400 mg/dL. SMOFlipid (mixed soybean/MCT/olive/fish) and Omegaven (pure fish oil) are preferred over pure soybean (Intralipid) for long-term PN to reduce intestinal failure-associated liver disease (IFALD). Maximum lipid dose is 2.5 g/kg/day; provide at minimum 100 g/week to prevent essential fatty acid deficiency.

What are the main complications of long-term parenteral nutrition?

Catheter-related bloodstream infection (CLABSI, 0.5-2 per 1000 catheter-days), catheter occlusion or thrombosis, intestinal failure-associated liver disease (IFALD, 40-60% with long-term soybean lipid), metabolic bone disease, micronutrient deficiencies (manganese, copper, selenium), and hyperglycemia. Cycling PN over 12-16 hours rather than continuous infusion reduces hepatic steatosis.

How is PN compounded for a 70 kg ICU patient?

Total energy 25 kcal/kg = 1750 kcal. Protein 1.5 g/kg = 105 g (420 kcal, 24%). Lipid 1 g/kg = 70 g (630 kcal, 36%, 350 mL of 20% lipid). Dextrose remaining 700 kcal / 3.4 kcal/g = 206 g (515 mL of 40% dextrose). Final volume ~2 L with sodium 80-100 mEq, potassium 60-80 mEq, calcium 10 mEq, magnesium 8-12 mEq, phosphate 20-40 mmol, plus standard multivitamins and trace elements.

© gomdori, MD · gomdorimedical.com · Educational content only — not a substitute for clinical judgment.
GUIDELINE REFERENCES

Primary guideline documents this article draws on. Links resolve via DOI to the publisher; access may require a subscription.

Leave a Reply

Your email address will not be published. Required fields are marked *